JOURNAL DESCRIPTION

The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.

Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.

Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.

The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.

Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.

The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.

Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.

The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.

Medical Radiology and Radiation Safety. 2019. Vol. 64. No. 2. P. 52–60

DOI: 10.12737/article_5ca5fc2765c9f5.02525917

V.S. Khoroshkov

History and Prospects of Proton Therapy

Institute for Theoretical and Experimental Physics, Moscow, Russia. E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. .

V.S. Khoroshkov – Head of Dep., Dr. Sci. Tech.

Abstract

Purpose: Presentation of the history, status and prospects for the development of proton therapy.

Material and methods: The history of proton therapy (PT) is divided into two periods. The first one – the experimental period lasted since 1954 to 1990, when proton therapy was carried out at the ten facilities in physical institutes. The research accelerators and the horizontal proton beams with a fixed direction are used. The second period is from 1990, when the first clinical proton center was commissioned in a multi-field hospital in the city of Loma Linda, USA. In the first period, the necessary technical tools were developed and the advantages of using accelerated protons in remote radiation therapy formulated by R. Wilson in 1946 were confirmed on a limited (about 9,000) patient population: halving the radiation load on the healthy tissues surrounding the tumor and on the organism as a whole compared to γ- and electron irradiation and high dose gradients at the borders of the dose distributions and the tumors. This allows to increase the dose in the tumor (target), increase the probability of the tumor resorption and at last to irradiate tumors, including small sizes, located near critical organs and structures. By 1990, in three experimental centers in Russia (JINR, ITEP, PNPI) accumulated about 30 % of world clinical experience.

Today, more than 70 multi-cabin and several single-cabin clinical based proton therapy centers operate in the world. Almost all centers are equipped with gantry installations for PT for 95 % of patients. Today proton therapy is indicated and is used for the treatment of 10–15 % of all malignancies of cancer incidence structure.

Results: Healthcare in Russia needs 10–15 multi-cabin proton (and ion) centers. Currently, there are one experimental PT center in the JINR, where up to 100 patients are exposed pea year. The modern proton center was commissioned at the Medical Institute Sergei Berezin in St. Petersburg with two gantry of company Varian. The IBA proton center in Dimitrovgrad is expected. The single-cabin proton complex of domestic production has been operating in Obninsk since 2017. 20th-century technologies and the horizontal beam (without the possibility of its rotation) are used in this complex for treatment of patients with small head and neck tumors.

Conclusion: Equipping the Russian health care facilities with proton therapy facilities is inevitable. Russia will buy them worldwide for decades, like almost all types of high-tech medical equipment, are bought today, or can produce them locally. All the prerequisites needed for production (rich physical – technical experience, scientific and industrial potential) are available.

Key words: proton therapy, cyclotron, synchrotron, gantry, Bragg curve, malignant neoplasm, local tumor control

REFERENCES

  1. Wilson RR. Radiological use of fast protons. Radiology. 1946;47:487-91.
  2. Proc. of the First Int. Sem. on the Uses of proton beams in Rad. Therapy, Moscow, 6–11 December, (Russian). State Committee of Atomic Energy of the USSR, Academy of Medical Sciences of the USSR. Moscow. Atomizdat, Vol. 1, 2, 3, 1979. (Russian).
  3. Abasov VI, Astrakhan BV, Blokhin NN, et al. Use of proton beams in the USSR for medical and biological porpoises. JINR, 1971, E–5854.
  4. Goldin LL, Vorontsov IA, Khoroshkov VS, Minakova EI. Proton therapy in the USSR М oscow: ITEP, 1988, Preprint № 102-88. (Russian).
  5. Proton Therapy Cooperative Group, PTCOG Newsletters. 1990(6).
  6. Report of the Advisory Group Meeting on the Utilization of Particle Accelerators for Proton Therapy. F1-AG -1010 (IAEA Headquarters. Vienna. 1998).
  7. Kostromin SA, Syresin EM, Trend in the accelerator technics for hadron therapy. Physics of Particles and Nuclei Letters, 2013;10(7/184):1346-75. (Russian).
  8. Klenov GI, Khoroshkov VS. Hadron therapy: history, status, perspectives. Advances in Physical Sciences. 2016;186(8):891. (Russian).
  9. Slater JM, at al. Proton beam irradiation: toward routine clinical utilization. Proc. of the First Int. Symp: on Hadron therapy. Italy. Como, 1993 Elsevier, 1994:130.
  10. Particle Therapy Cooperative Group. http://www.ptcog52–58.org/
  11. Masashi Mizumoto, Yoshiko Oshiro, Koji Tsuboi. Proton beam therapy for intracranial and skull base tumors. Translational Cancer Research. 2012;2(2):3.
  12. www.csintell.com/marketr.html.
  13. MEVION Medical System, http://www.mevion.com.
  14. Ion Beam Application Proton Therapy, https://iba-worldwide.com/proton-therapy.
  15. Bulanov SV, Khoroshkov VS. On the use of the Laser Accelerators in proton Therapy. Particles, PTCOG Newsletter. 2002;(29):10.
  16. Bulanov SV, Khoroshkov VS. Possibility to use laser accelerators in proton therapy. Plasma Physics Reports. 2002;28(5):493-6. (Russian).
  17. Stolpner AZ. Medicine: Targeted projects, 2013;15:28. (Russian).
  18. Medical Radiology Center and Science Campus in Dimitrovgrad www.dimra.ru. (Russian).
  19. Company “Protom” www.protom.ru. (Russian).
  20. Pryanichnikov АА , Sokunov VV, Shemyakov AE. Some results of clinical use of proton therapy complex Prometheus. Physics of Particles and Nuclei Letters, 2018;15(7):975. (Russian).
  21. Khmelevsky EV. The need for proton radiation therapy in Russia by 2010. Voprosy oncology. 2009;55(4):430. (Russian).

For citation: Khoroshkov VS. History and Prospects of Proton Therapy. Medical Radiology and Radiation Safety. 2019;64(2):52-60. (Russian).

DOI: 10.12737/article_5ca5fc2765c9f5.02525917

PDF (RUS) Full-text article (in Russian)

Contact Information

 

46, Zhivopisnaya st., 123098, Moscow, Russia Phone: +7 (499) 190-95-51. E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Journal location

Attendance

2759500
Today
Yesterday
This week
Last week
This month
Last month
For all time
2231
3035
17884
18409
67243
75709
2759500

Forecast today
2280


Your IP:216.73.216.75